Liquid biopsies offer hope for earlier treatment, better tracking of ovarian cancer

A promising new way to monitor and treat recurrence of ovarian cancer has been identified by researchers — a hard-to-detect disease that claims many lives. New research finds liquid biopsies from blood tests and DNA sequencing can detect a return of ovarian cancer long before a tumor reappears. (Mehr in: Cancer News — ScienceDaily)